Sangel Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Sangel Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 11, 2021	China Immunotech	$31.0M Series B	China Growth Capital	Beijing Changping Science Park Development, Fenghai Capital, Guangzhou Sanheyue, Start Point Advisors, Jianwei YUAN
Feb 11, 2021	Ascentawits	$15.5M Pre-Series B	—	—
Oct 26, 2020	Sirnaomics	$105.0M Series D	Donald Dai, shi shenghao, Yunchun Li	Alpha Win Capital, HongTao Capital, Longmen Capital
Oct 31, 2019	Denovo Biopharma	$42.5M Series B	—	—
Jun 6, 2018	Sirnaomics	$25.0M Series C	—	HuaKong Equity Investment, Qianhai Shenghui Investment
May 2, 2018	Refuge Biotechnologies	$25.0M Series B	Dr. Jing Lou, Neil Shen	3E Bioventures Capital, Danhua Capital, Ocean Pine Healthcare Fund, ShangBay Capital, WuXi Healthcare Ventures
Jan 5, 2018	KBP Biosciences	$76.0M Series A	Benjamin Qiu, Jianping Tang	Fred Craves, Cash Capital, Efung Capital, Elite Capital, GF Xinde Life Science Investment Fund, Korea Investment Partners, Ping An Ventures
Jan 1, 2018	Ultivue	$20.0M Series B	ARCH Venture Partners	6 Dimensions Capital, Kilonova Capital, Applied Ventures, Yonghua Capital